ConductScience.org, home

Paper41222508

Challenges of Conducting Risk-Benefit Analysis of Early Phase Clinical Trials: Results of a National Survey of IRB Chairs.

Baugh CM and 7 others. Ethics Hum Res, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Challenges of Conducting Risk-Benefit Analysis of Early Phase Clinical Trials: Results of a National Survey of IRB Chairs. Papers, record 41222508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41222508

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Challenges of Conducting Risk-Benefit Analysis of Early Phase Clinical Trials: Results of a National Survey of IRB Chairs.
PubMed
Journal
Ethics Hum Res
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-25
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baugh CMChristine M
2Bolcic-Jankovic DDragana
3Fedyk MMark
4Yarborough MMark
5Hey SPSpencer Phillips
6Hyun IInsoo
7Kimmelman JJonathan
8Campbell EGEric G

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ethics Committees, ResearchMajor topic
Clinical Trials as TopicMajor topic
Humans
Surveys and Questionnaires
Risk Assessment

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 NS119622NINDS NIH HHSUnited StatesR01NS119622PubMed and NIHNIH RePORTER
NINDS 5 R01 NS119622-3National Institutes of Neurologic Diseases and StrokePubMedPubMed

Download CSV of grants

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122622205How closely do institutional review boards follow the common rule?Acad Med2012https://conductscience.org/library/papers/22622205PubMed
217549248Gene therapy for severe combined immunodeficiency: are we there yet?J Clin Invest2007https://conductscience.org/library/papers/17549248PubMed
319798046Variation among institutional review boards in evaluating the design of a multicenter randomized trial.J Perinatol2010https://conductscience.org/library/papers/19798046PubMed
424844265Distinguishing between exploratory and confirmatory preclinical research will improve translation.PLoS Biol2014https://conductscience.org/library/papers/24844265PubMed
539116871Preclinical assessment for translation to humans: The PATH approach for assessing supporting evidence for early-phase trials and innovative care.Med2024https://conductscience.org/library/papers/39116871PubMed
621871046Views and experiences of IRBs concerning research integrity.J Law Med Ethics2011https://conductscience.org/library/papers/21871046PubMed
717393970Ethical attitudes of nurse, physician, and unaffiliated members of institutional review boards.J Nurs Scholarsh2007https://conductscience.org/library/papers/17393970PubMed
818463365Cell-based interventions for neurologic conditions: ethical challenges for early human trials.Neurology2008https://conductscience.org/library/papers/18463365PubMed
923874156Evaluation of excess significance bias in animal studies of neurological diseases.PLoS Biol2013https://conductscience.org/library/papers/23874156PubMed
1032990501Exception From Informed Consent: How IRB Reviewers Assess Community Consultation and Public Disclosure.AJOB Empir Bioeth2021https://conductscience.org/library/papers/32990501PubMed
1117470507A qualitative study of institutional review board members' experience reviewing research proposals using emergency exception from informed consent.J Med Ethics2007https://conductscience.org/library/papers/17470507PubMed
1228150789Consider drug efficacy before first-in-human trials.Nature2017https://conductscience.org/library/papers/28150789PubMed
1321460582A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn.J Empir Res Hum Res Ethics2011https://conductscience.org/library/papers/21460582PubMed
1419566438Grinding to a halt: the effects of the increasing regulatory burden on research and quality improvement efforts.Clin Infect Dis2009https://conductscience.org/library/papers/19566438PubMed
1541222508Challenges of Conducting Risk-Benefit Analysis of Early Phase Clinical Trials: Results of a National Survey of IRB Chairs.Ethics Hum Res2025https://conductscience.org/library/papers/41222508PubMed
1626225553A Scoping Review of Empirical Research Relating to Quality and Effectiveness of Research Ethics Review.PLoS One2015https://conductscience.org/library/papers/26225553PubMed
1729874243The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials.PLoS Biol2018https://conductscience.org/library/papers/29874243PubMed
1826168043Industry Relationships Among Academic Institutional Review Board Members: Changes From 2005 Through 2014.JAMA Intern Med2015https://conductscience.org/library/papers/26168043PubMed
1915301198Making risk-benefit assessments of medical research protocols.J Law Med Ethics2004https://conductscience.org/library/papers/15301198PubMed
2026463620Assessing risk/benefit for trials using preclinical evidence: a proposal.J Med Ethics2016https://conductscience.org/library/papers/26463620PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
41222508Challenges of Conducting Risk-Benefit Analysis of Early Phase Clinical Trials: Results of a National Survey of IRB Chairs.Ethics Hum Res2025https://conductscience.org/library/papers/41222508

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41222508

GET https://conductscience.org/api/papers/v1/41222508/authors